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Abstract
Numerous lines of evidence support a relationship between intestinal inflammation and cancer. Therefore, much attention has recently
been focused on the identification of natural compounds with anti-inflammatory activities as a strategy to suppress the early stages of color-
ectal cancer. Because cocoa is a rich source of bioactive compounds, the present study investigated its anti-inflammatory properties in a rat
model of azoxymethane (AOM)-induced colon carcinogenesis and in TNF-a-stimulated Caco-2 cells. A total of forty male rats were fed with
control or cocoa-enriched diets (12 %) during 8 weeks and injected with saline or AOM (20 mg/kg body weight) during the third and fourth
week (n 10 rats/group). At the end of the experiment, colon samples were evaluated for markers of inflammation. The anti-inflammatory
activity of a cocoa polyphenolic extract (10mg/ml) was examined in TNF-a-stimulated Caco-2 cells, an in vitro model of experimentally
induced intestinal inflammation. The signalling pathways involved, including NF-kB and the mitogen-activated protein kinase family such
as c-Jun NH2-terminal kinases (JNK), extracellular signal-regulated kinases and p38, were also evaluated. The results show that the
cocoa-rich diet decreases the nuclear levels of NF-kB and the expression of pro-inflammatory enzymes such as cyclo-oxygenase-2 and
inducible NO synthase induced by AOM in the colon. Additionally, the experiments in Caco-2 cells confirm that cocoa polyphenols effec-
tively down-regulate the levels of inflammatory markers induced by TNF-a by inhibiting NF-kB translocation and JNK phosphorylation.
We conclude that cocoa polyphenols suppress inflammation-related colon carcinogenesis and could be promising in the dietary prevention
of intestinal inflammation and related cancer development.
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Colorectal cancer (CRC) is a major healthcare problem and
the third most common cause of all cancer deaths(1). Colon
carcinogenesis is a complex multistep process from small
benign precursor lesions to metastatic carcinomas(2). During
this progression, chronic inflammation is causally linked to
carcinogenesis and acts as a driving force in the premalignant
and malignant transformation of cells(3).
The early stages of colon carcinogenesis involve an increase
in the pro-inflammatory enzymes cyclo-oxygenase-2 (COX-2)
and inducible NO synthase (iNOS)(4). COX-2 and iNOS are
implicated in chronic inflammation, which creates a microen-
vironment contributing to the development of preneoplastic
lesions in colon carcinogenesis(5). More importantly, inhibition
of these two enzymes has shown protective effects against
colon tumour development in different animal models,
suggesting that they are crucial targets for mucosal
inflammation and colon tumorigenesis(6). Likewise, the
redox-sensitive eukaryotic transcription factor NF-kB that
regulates the expression of iNOS and COX-2 has been related
to inflammation-induced colon carcinogenesis and its inhi-
bition also prevents cancer progression(7). Therefore, the use
of chemo-preventive compounds that suppress inflammation
seems to be a useful strategy to control the development
and progression of CRC.
Accordingly, considerable attention has recently been
focused on the identification of dietary bioactive compounds
with anti-inflammatory activities as an alternative natural
source for the prevention of inflammation-associated dis-
eases(8). Evidence from epidemiological studies suggests that
a high consumption of fruits and vegetables and the intake
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of certain non-nutrients that are present in foods reduce the
risk of CRC(9). These beneficial effects have been partly
attributed to polyphenolic phytochemicals, which have a
wide range of pharmacological properties, including antioxi-
dant, anti-inflammatory and anti-carcinogenic activities(10).
The molecular mechanisms underlying their chemo-preven-
tive effects have been associated with the modulation of sig-
nalling cascades, gene expression involved in the regulation
of cell proliferation and apoptosis and the suppression of
chronic inflammation(11).
Cocoa is a rich source of bioactive compounds such as poly-
phenols and methylxanthines, mainly theobromine and, in a
much smaller quantity, caffeine. Cocoa contains high amounts
of the flavonoids (2)-epicatechin, (þ)-catechin and procyani-
dins B2 and B1, although other polyphenols such as quercetin,
isoquercitrin (quercetin 3-O-glucoside), quercetin 3-O-arabi-
nose, hyperoside (quercetin 3-O-galactoside), naringenin,
luteolin and apigenin have also been found in minor quan-
tities(12). At present, cocoa and its phenolic compounds
have attracted a great deal of interest because of their potential
ability to act as highly effective chemo-preventive agents(13,14).
As antioxidants, cocoa flavanols have been shown to protect
cell constituents, limiting the risk factor for cancer and other
chronic diseases(15). Accordingly, we have recently shown
that a cocoa-rich diet could prevent the early stages of colon
carcinogenesis by reducing oxidative stress and cell prolifer-
ation and by inducing apoptosis(16). Additionally, cocoa flava-
nols can display other chemo-preventive properties which
may be independent of conventional antioxidant activities.
In particular, recent in vitro studies have demonstrated that
cocoa phenolic compounds exhibited a variety of potential
anti-inflammatory effects in intestinal cells(17), which may con-
tribute to their cancer chemo-preventive activity. However,
those mechanisms have not yet been investigated in in vivo
studies of colon carcinogenesis.
Considering this, in the present study, we have used the
well-defined azoxymethane (AOM)-induced colon cancer
model in rats to investigate the anti-inflammatory effect of a
cocoa-rich diet. In addition, to gain further insight into the
mechanisms involved, we tested the anti-inflammatory effect
of a cocoa polyphenolic extract (CPE) in an in vitro model
of inflammation using human intestinal Caco-2 cells and
TNF-a as a pro-inflammatory stress. Caco-2 cells constitute a
widely known and well-established in vitro model of the
human intestinal barrier commonly used to test the ability of
dietary substances to modulate intestinal inflammation(18–20).
The present results indicated that cocoa polyphenols could
suppress intestinal inflammation in vivo and in vitro through
the inhibition of NF-kB signalling and the down-regulation
of pro-inflammatory enzyme expression.
Materials and methods
Materials and chemicals
AOM, o-phthalaldehyde, gentamicin, penicillin G and strepto-
mycin were purchased from Sigma Chemical. Anti-extracellular
signal-regulated kinases (ERK), anti-phospho-ERK (p-ERK),
anti-JNK, anti-phospho-JNK (p-JNK), anti-phospho-p38 and
anti-b-actin were obtained from Cell Signaling Technology.
Anti-p38, anti-p65 (NF-kB), anti-iNOS and anti-COX-2 were
purchased from Santa Cruz Biotechnology. The RNA isolation
kit was obtained from Applied Biosystems/Ambion, primers
for RT-PCR were from Isogen, dNTP and RT were from
Promega and Taq polymerase was obtained from Roche.
Recombinant murine TNF-a was from PreproTech. Materials
and chemicals for electrophoresis and the Bradford reagent
were from BioRad Laboratories S.A. Cell-culture dishes were
from Falcon and cell-culture medium and fetal bovine serum
(FBS) from Biowhittaker Europe (Innogenetics).
Cocoa
Natural Forastero cocoa powder (a kind gift from Nutrexpa)
was used for the present study.
For the in vivo experiments, diets were prepared from
an AIN-93G formulation (Panlab S.L.). The 12 % cocoa diet
was produced by adding 120 g/kg cocoa to AIN-93G at
the expense of starch and cellulose. As a result, the cocoa
diet was slightly richer in proteins (2·6 %) and lipids (1·2 %)
but, in order to make both diets isoenergetic (15 048 kJ/kg),
the content in carbohydrate was slightly reduced (5 %).
The composition of the diets is given in Table 1.
For the in vitro experiments, a CPE was prepared from
the same Natural Forastero cocoa powder by sequentially
washing 1 g of cocoa with 40 ml of 16 mM-HCl in 50 % aqueous
methanol (50:50, v/v, 1 h at room temperature, constant
shaking) and 40 ml of acetone–water (70:30, v/v, 1 h at
room temperature, constant shaking) in 50 ml centrifuge
tubes. After centrifugation (15 min, 3000g), supernatants
from each extraction step were combined and made up to
100 ml. The desiccated extract was dissolved in distilled
Table 1. Composition of the experimental control and
cocoa-rich diets
Components (g/kg dry weight) Control Cocoa
Casein 140 140
Dextrose 155 155
Sucrose 100 100
Fat 40 40
t-BHQ 0·008 0·008
Mineral mix 35 35
Vitamin mix 10 10
L-Cys 1·8 1·8
Choline bitartrate 2·5 2·5
Cellulose 100 59·2
Starch 415·7 336·5
Cocoa powder – 120
Total cocoa polyphenols* – 2·4
Cocoa flavonoids†
Procyanidin B1 – 0·042
Catechin – 0·139
Procyanidin B2 – 0·159
Epicatechin – 0·459
Theobromine† – 0·891
t-BHQ, tert-butylhydroquinone.
* Cocoa polyphenols were determined by the Folin–Ciocalteu
method.
† Main cocoa flavonoids and theobromine were determined by
liquid chromatography–MS(17).
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water and kept frozen until assay. The total polyphenol content
of the CPE was determined by the spectrophotometric method
of Folin–Ciocalteu using gallic acid as the standard. A Beckman
DU640 spectrophotometer (Beckman Instruments, Inc.) was
used. The phenolic fraction of the CPE was previously
analysed by liquid chromatography–MS(21). Accordingly, the
polyphenolic profile of the CPE showed that monomeric epica-
techin and catechin were the major flavanols in the extract,
together with appreciable amounts of procyanidins B1 and B2.
Additionally, theobromine was present in high amounts while
only traces of caffeine were detected in the extract (Table 1).
Animals and experimental design
A total of forty male Wistar Han rats (5 weeks old) were
purchased from Harlan Laboratories Models, S.L. The animals
were placed individually in stainless-steel wire-bottomed
metabolism cages housed in a room under controlled con-
ditions (19–238C, 50–60 % humidity and 12 h light–dark
cycles). After 1 week of acclimatisation, rats were randomly
assorted into four different experimental groups (Fig. 1(A))
and were provided with food and water ad libitum. Of these
four groups, two received a standard diet (control) and two
were fed with the cocoa-rich diet (cocoa). At 2 weeks later,
one control and one cocoa group were intraperitoneally
injected with AOM (20 mg/kg body weight) and the other
control and cocoa groups with saline, once per week for
two consecutive weeks. Rats were killed in the 8th week
and the entire colon was resected and cleaned with PBS.
Sections (1 cm) from the most distal portion of the colon
were fixed in 10 % neutral-buffered formalin for histological
and immunohistochemical analyses. The remaining mid-
section of the colon was used for mRNA analyses. The animals
were treated according to Institutional Care Instructions
(Bioethical Commission from Consejo Superior de Investiga-
ciones Cientificas, CSIC, Spain).
Cell culture and treatments
Caco-2 cells were a kind gift from Dr Sonia de Pascual-Teresa
(ICTAN-CSIC, Madrid, Spain). Cells (ECACC 86010202) were
originally obtained from the European Collection of Cell
Cultures (ECACC) and were used between passages 40 and
60. Caco-2 cells were maintained in a humidified incubator
containing 5 % CO2 and 95 % air at 378C and were grown on
100 mm-diameter culture plates in Dulbecco’s modified
Eagle’s medium F12 from Biowhittaker, supplemented with
10 % Biowhittaker fetal bovine serum and 50 mg/l of each of
the following antibiotics: gentamicin; penicillin; streptomycin.
The plates were changed to a fetal bovine serum-free medium
the day before the assay.
For the TNF-a treatment, different concentrations of TNF-a
(10, 20 and 40 ng/ml), diluted in serum-free culture medium,
were added to the cell plates. The concentration range was
determined according to the literature(22) and the absence of
cytotoxicity was verified by the crystal violet method. For
the CPE treatment, 10mg/ml of CPE diluted in serum-free cul-
ture medium and filtered through a 0·2mm membrane were
added to the cell plates for 20 h. This concentration of the
CPE in cell cultures is comparatively equivalent to realistic
concentrations in the human gut and evoked a significant
protection against oxidative stress in Caco-2 cells(23). In the
present study, the culture medium containing the CPE was
removed after 20 h pretreatment and a fresh culture medium
containing pro-inflammatory TNF-a added for 24 h.
Histological and immunohistochemical analyses
Samples from the distal colon fixed in 10 % neutral-buffered
formalin were sectioned and stained with haematoxylin and
eosin for histological evaluation. NF-kB-p65 immunohisto-
chemistry was performed in histological sections of colonic
mucosa. Briefly, serial sections of the colon were deparaffi-
nised in xylene, rehydrated in graded ethanol, washed in
PBS and heated in a microwave at 988C, with 0·01 M-sodium
citrate buffer (pH 6·0). Peroxide blocking was performed
with 0·3 % H2O2 in methanol at room temperature for 5 min.
The sections were incubated with rabbit polyclonal anti-NF-
kB-p65 (dilution 1:100) at 48C overnight. A secondary anti-
body, goat anti-rabbit, was then applied for 30 min in a
1:200 dilution. Slices were incubated with horseradish
peroxidase-conjugated streptavidin and then visualised
with 3,30-diaminobenzidine and counterstained with Harris’s
Control + AOM
(A)
CocoaControl Cocoa + AOM
(B)
0 1 2 3 4 5 6 7 8 weeks
Control
AOMAOM K
Cocoa
Control + AOM
Cocoa + AOM
Fig. 1. (A) Experimental design for azoxymethane (AOM, 20 mg/kg body weight)-induced colon carcinogenesis in rats. (B) Representative haematoxylin and
eosin-stained sections of the colon of rats injected with saline or AOM and fed with the control ( ) or cocoa-enriched diet ( ) (100£). K, killing.
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haematoxylin. NF-kB (p65) expression was detected as nuclear
and cytoplasmic brown staining. The number of nuclear NF-kB
(p65)-positive epithelial cells was examined under light
microscopy at 400£ magnification (a Leica DM LB2 microscope
and a digital Leica DFC 320 camera; Leica Microsystems) and
quantified by a percentage score (mean values with their
standard errors) with grading between 0 and 4: 0, no nuclear
staining; 1, 1–10 % positive cells; 2, 10–30 % positive cells; 3,
30–60 % positive cells; 4, 60–100 % positive cells. As a positive
internal control, we used NF-kB/p65 expression in lympho-
cytes and endothelial cells of the tissue sample, which
showed positive nuclear staining in all runs. Negative controls
were used during the optimisation of the method.
Determination of cyclo-oxygenase-2 and inducible nitric
oxide synthase expression in colon tissues
Total RNA was extracted from the rat distal colon using the
RNA isolation kit (Totally RNA kit; Applied Biosystems/
Ambion) as described in the manufacturer’s manual. Total
RNA (1mg) was subjected to RT and the complementary
DNA products were amplified by PCR using the following
couples of primers: 50-CCCTTCCGAAGTTTCTGGCAGCAGC-30
and 50-GGCTGTCAGAGAGCCTCGTGGCTTTGG-30 for ampli-
fication of iNOS; 50-GGAGAGACTATCAAGATAGTGATC-30
and 50-ATGGTCAGTAGACTTTTACAGCTC-30 for COX-2;
50-ACCACAGTCCATGCCATCAC-30 and 50-TCCACCACCCTGT-
TGCTGTA-30 for glyceraldehyde 3-phosphate dehydrogenase
as a housekeeping gene. The samples were incubated in a
Thermo Cycler (PCR Express; Thermo Hybaid) using the fol-
lowing parameters: 948C for 1 min, 648C for 1 min and 728C
for 1 min (thirty-five cycles) followed by a 10 min extension
at 728C for COX-2 amplification; 948C for 1 min, 558C for
1 min and 728C for 1 min (thirty-five cycles) followed by a
10 min extension at 728C for iNOS and 928C for 1 min, 558C
for 1 min and 728C for 1 min (thirty-five cycles) followed by
a 10 min extension at 728C for glyceraldehyde 3-phosphate
dehydrogenase amplification. The PCR products were electro-
phoresed on a 1·5 % agarose gel containing ethidium bromide.
The gel was photographed under UV transillumination and
the bands were quantified by laser scanning densitometry
(Molecular Dynamics). Band intensity was normalised to
values for glyceraldehyde 3-phosphate dehydrogenase that
was used as an internal control.
Determination of IL-8 secretion by Caco-2 cells
Concentration of IL-8 in cell-culture supernatants was deter-
mined using a human IL-8 ELISA kit (BD Biosciences)
according to the manufacturer’s instructions. The ELISA
ninety-six-well microplates were analysed using a microplate
reader at 570 nm (Bio-Tek).
Preparation of cell lysates for Western blotting
To detect ERK, p-ERK, JNK, p-JNK, p38, p-p38, iNOS and
COX-2 levels, Caco-2 cells were lysed at 48C in a buffer
containing 25 mM-HEPES (pH 7·5), 0·3 M-NaCl, 1·5 mM-MgCl2,
0·2 mM-EDTA, 0·5 mM-1,4-dithiothreitol, 0·1 % Triton X-100,
200mM-b-glycerolphosphate, 0·1mM-Na3VO4, 2mg leupeptin/ml
and 1 mM-phenylmethylsulphonyl fluoride. The supernatants
were collected, assayed for protein concentration using the
Bradford reagent, aliquoted and stored at 2808C until used for
Western blot analyses.
Preparation of nuclear and cytosolic cellular extracts
To evaluate the cytosolic and nuclear NF-kB-p65 content,
cells were resuspended at 48C in 10 mM-HEPES, pH 7·9,
1·5 mM-MgCl2, 10 mM-KCl, 0·5 mM-1,4-dithiothreitol and
0·2 mM-phenylmethylsulphonyl fluoride (buffer A), allowed
to swell on ice for 10 min, and then vortexed for 10 s. The
samples were centrifuged at 10 000 g for 2 min and the
supernatant containing the cytosolic fraction was stored at
2808C. The pellet was resuspended in cold buffer B
(20 mM-HEPES, pH 7·9, 25 % glycerol, 420 mM-NaCl, 1·5 mM-
MgCl2, 0·2 mM-EDTA, 0·5 mM-1,4-dithiothreitol, 0·2 mM-phenyl-
methylsulphonyl fluoride, 2·5mg leupeptin/ml and 2·5mg
aprotinin/ml) and incubated on ice for 20 min for high salt
extraction. Cellular debris was removed by centrifugation at
13 000g for 10 min at 48C, and the supernatant fraction
containing the nuclear protein extract was stored at 2808C.
Protein content was measured using the Bradford reagent.
Protein determination by Western blotting
Equal amounts of protein (40mg) were separated by
SDS–PAGE and transferred to polyvinylidene difluoride
filters (Protein Sequencing Membrane). Membranes were
probed with the corresponding primary antibody followed
by incubation with peroxide-conjugated anti-rabbit Ig (GE
Healthcare). Blots were developed with the enhanced chemi-
luminescence (ECL) system (GE Healthcare). Anti-growth
factor receptor-bound protein 2 and anti-poly (ADP-ribose)
polymerase (PARP) antibodies were used as markers for
the cytosolic and nuclear extracts, respectively. Normalisation
of the Western blot was ensured by b-actin and band quanti-
fication was carried out with a scanner (HP Scanjet G2710; HP)
and Scion Image software (Scion Corporation).
Statistical analysis
Following assurance of the normal distribution of data,
Student’s t test was used to assess the statistical significance
of aberrant crypt foci (ACF) formation between the control þ
AOM and cocoa þ AOM groups. In the rest of the compari-
sons, one-way ANOVA was used followed by a Bonferroni
test when variances were homogeneous or by the Tamhane
test when variances were not homogeneous. Differences
were considered as statistically significant if P,0·05 (statistical
package SPSS version 19.0; SPSS, Inc.).
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Results
General observations and histological changes
During the study period, rats fed with the cocoa diets had food
intakes similar to their corresponding control animals
(data not shown). However, the body weight of the animals
fed with the cocoa diet was slightly but significantly reduced
when compared with the control groups (about 10 %) at
weeks 5–7. As described elsewhere, this effect has been attrib-
uted to a reduced fat adipose tissue in rats consuming a cocoa
diet(24,25). On the other hand, there was no difference among
the colon weights or lengths of any group of animals at the
time of killing (data not shown). Furthermore, gross obser-
vation of liver, lung and kidney indicated no pathological
alterations in any organ among the groups.
After haematoxylin and eosin staining, sections from the
control þ AOM group showed signs of diffuse inflammation
with the destruction of the epithelial architecture and the
loss of crypts (Fig. 1(B)). The epithelial crypts were distorted
and irregularly distributed in the lamina propria, which con-
tains high numbers of inflammatory cells, including lympho-
cytes, plasma cells and polymorphonuclear leucocytic cells.
The preneoplastic lesions in the epithelial layer of colonic
mucosa were identified after careful histological examination
involving dysplastic aberrant crypts, hypercellularity with
enlarged hyperchromatic nuclei, loss of polarity and
decreased mucine excretion. Treatment with cocoa reduced
the morphological alteration associated with AOM adminis-
tration, protecting the mucosal architecture, reducing crypt
and epithelial damage and showing scarce infiltration of
inflammatory cells. No histological modification was present
in the colon of rats fed with control and cocoa diets.
Cocoa-enriched diet reduced the colonic expression of
cyclo-oxygenase-2, inducible nitric oxide synthase and
NF-kB (p65) induced by azoxymethane
Next, we investigated the effect of cocoa administration in the
expression of inflammatory enzymes COX-2 and iNOS that are
often elevated in the initial phase of carcinogenesis induced
by AOM. As shown in Fig. 2(A), injection of AOM markedly
elevated the expression of COX-2 and iNOS mRNA in the
colon, while cocoa feeding effectively suppressed this
elevation. It is worth noting that cocoa feeding alone was
able to significantly reduce COX-2 expression in non-AOM
rats to levels below those of control non-AOM rats.
Given that the expression of both inflammatory proteins is
regulated by NF-kB, the levels of the p65 subunit of NF-kB
in the nucleus of colonocytes (active form) were then
measured. To this end, immunohistochemical staining was
performed in the local colonic tissue. As shown in Fig. 2(B),
there was a little expression of immunoreactive NF-kB-p65
in the control or cocoa distal colon tissues that was mainly
localised in stromal cells. On the contrary, strong NF-kB-p65
expression was detected in both epithelial and stromal cells
in the colon of the control þ AOM or cocoa þ AOM group.
Nevertheless, the scores for NF-kB-p65 in the cocoa groups
were significantly smaller than those of the control þ AOM
group, indicating that cocoa supplementation significantly
reduces NF-kB activity in colonic mucosa.
Cocoa polyphenolic extract treatment protects TNF-a-
induced inflammatory marker expression in Caco-2 cells
In order to confirm that the positive effects of the cocoa diet
could be related to its polyphenol content and to gain further
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Fig. 2. Effect of the cocoa-enriched diet on the colonic expression of cyclo-oxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) and NF-kB induced by
azoxymethane (AOM). (A) Representative RT-PCR analysis and percentage values of mRNA levels of COX-2 and iNOS in the distal colon mucosa of rats injected
with saline or AOM and fed with the control or cocoa-enriched diet. (B) Representative photographs for immunohistochemical staining of NF-kB subunit p65 (dark
brown)-positive cells (400£ magnification) and the percentage score in colon tissues from rats injected with saline or AOM and fed the control or cocoa-enriched
diet. Values are means from six to eight rats in each group, with standard deviations represented by vertical bars. a,b,c Mean values with unlike letters were signifi-
cantly different (P,0·05). GADPH, glyceraldehyde 3-phosphate. , Control; , control þ AOM; , cocoa; , cocoa þ AOM.
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insight into the mechanism involved, we next investigated the
anti-inflammatory activity of a CPE obtained from cocoa used
in the in vivo experiment. To this end, the effects of the CPE
on intestinal inflammation were investigated in TNF-a-stimu-
lated Caco-2 cells, an in vitro model of experimentally
induced intestinal inflammation. Accordingly, Caco-2 cells
were exposed for 24 h to different concentrations of TNF-a
and the levels of the pro-inflammatory marker IL-8 were eval-
uated. Fig. 3(A) shows that IL-8 secreted in the culture
medium by Caco-2 cells in response to TNF-a augmented in
a dose-dependent manner, being significantly increased at
40 ng/ml of TNF-a. Since this was the minimal dose able to
induce the inflammation of Caco-2 cells, it was the one
selected for the subsequent experiments. Likewise, the levels
of the inflammatory enzymes COX-2 and iNOs, evaluated
by Western blot, were significantly enlarged in Caco-2 cells
after 24 h of stimulation with 40 ng/ml of TNF-a (Fig. 3(B)
and (C)). To determine whether the CPE could reduce
these inflammatory responses, Caco-2 cells were then pre-
treated for 20 h with 10mg/ml of CPE supplying 132 nM-epica-
techin, 40 nM-catechin and 43 nM-procyanidin B2. Since cocoa
polyphenols can be largely found in the gastrointestinal tract
even at micromolar concentrations, 10mg/ml of CPE represent
a realistic concentration in the human gut. After that, CPE-trea-
ted cells were further stimulated with TNF-a (40 ng/ml) for
24 h. As shown in Fig. 4, pretreatment of Caco-2 cells with
CPE significantly reduced the IL-8 release (Fig. 4(A)) and
down-regulated the levels of COX-2 and iNOS in Caco-2
cells stimulated with TNF-a (Fig. 4(B) and (C)).
Cocoa polyphenolic extract regulates NF-kB and
mitogen-activated protein kinase in Caco-2 cells
Finally, to elucidate the mechanism responsible for the anti-
inflammatory action of cocoa polyphenols, we examined the
upstream pathways for COX-2 and iNOS stimulation, which
are rapidly activated after TNF-a treatment. Accordingly,
the nuclear and cytosolic levels of NF-kB were evaluated by
Western blot. As shown in Fig. 5(A) and (B), stimulation of
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Fig. 3. Effect of TNF-a on IL-8 secretion and cyclo-oxygenase-2 (COX-2) and
inducible nitric oxide synthase (iNOS) expression in Caco-2 cells. Values
are means, with standard deviations represented by vertical bars. (A) Cells
were treated with 10, 20 and 40 ng/ml TNF-a for 24 h and IL-8 secretion was
evaluated by ELISA. (B) Cells were treated with 40 ng/ml TNF-a for 24 h and
COX-2 and iNOS levels were evaluated by Western blot. Representative
bands of three different experiments. (C) Percentage values of COX-2 and
iNOS levels relative to the control condition. a,b Mean values with unlike letters
were significantly different (P,0·05). , Control; , TNF-a.
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Fig. 4. Effect of the cocoa polyphenolic extract (CPE) treatment in
TNF-a-induced IL-8 secretion and cyclo-oxygenase-2 (COX-2) and inducible
nitric oxide synthase (iNOS) expression in Caco-2 cells. C ( ): control,
untreated cells; TNF-a ( ): cells treated with 40 ng/ml TNF-a for 24 h; CPE
( ): cells treated with 10mg/ml CPE for 20 h; CPE þ TNF-a ( ): cells pre-
treated with 10mg/ml CPE for 20 h and then treated with 40 ng/ml TNF-a for
24 h. (A) IL-8 secretion was evaluated by ELISA. (B) COX-2 and iNOS levels
were evaluated by Western blot. Representative bands of three different
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to the control condition. Values are means, with standard deviations
represented by vertical bars. a,b,c Mean values with unlike letters were signifi-
cantly different (P,0·05).
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Caco-2 cells with TNF-a during 60 min increased accumulation
of the p65 subunit of NF-kB in the nucleus, while 20 h
pretreatment of cells with the CPE significantly prevented
TNF-a-induced NF-kB translocation.
The induction of NF-kB by TNF-a is partially mediated by
members of the mitogen-activated protein kinase family
(MAPK), such as c-Jun NH2-terminal kinases (JNK), ERK and
p38. Then, we determined the activation of these MAPK by
TNF-a by measuring the levels of phosphorylated JNK, ERK
and p38. As shown in Fig. 5(C) and (D), all MAPK were
strongly activated upon 60 min of TNF-a stimulation.
The CPE pretreatment did not block ERK and p38 activation
but strongly inhibited the activation of JNK. In addition, 20 h
of CPE treatment induced the activation of ERK and p38 in
Caco-2 cells.
Discussion
The present study was performed to investigate the potential
anti-inflammatory effect of cocoa polyphenols and to eluci-
date the molecular mechanism involved. In a previous
study, we demonstrated that a cocoa-rich diet could prevent
the early stage of CRC in rats(16). The chemo-preventive effects
elicited by cocoa were due at least in part to its ability to
prevent oxidative stress and cell proliferation and to induce
apoptosis. Herein we show for the first time that cocoa flavo-
noids also prevent colon inflammation in AOM-treated rats
and in TNF-a-stimulated Caco-2 cells, which contributes to
its anti-carcinogenic activity.
The AOM colon cancer model has been extensively used to
examine the chemo-preventive effect of numerous compounds
on CRC(26). Administration of the colon-specific carcinogen
AOM to rodents induces oxidative stress and inflammation
that results in chromosomal instability and DNA damage in
proliferating cells contributing to malignant transformation(27).
In the present study, we showed that feeding animals with
a cocoa-rich diet strongly prevents inflammatory tissue
damage and cellular infiltration in colonic mucosa. This
result is in concordance with previous reports indicating that
some polyphenolic compounds including genistein(28),
limonin(29) and silibinin(30) possess anti-inflammatory effects
in vivo on the colonic tissue. More importantly, two single
doses of a CPE reduced colon damage and neutrophil infiltra-
tion in an acute model of dextran sulphate sodium-induced
ulcerative colitis in mice(31). Indeed, we have recently
shown that a cocoa rich-diet prevents the development of
colonic preneoplastic lesions (ACF) induced by AOM(16);
therefore, we suggest that the reduction of intestinal inflam-
mation by cocoa could be one of the causal mechanisms for
the prevention of the early steps of colon carcinogenesis.
The anti-inflammatory activity of a cocoa diet was thus
investigated as one underlying mechanism of its efficacy in
inhibiting AOM-induced ACF formation in the rat colon. We
found that a cocoa-rich diet markedly inhibited the expression
of enzymes associated with inflammation, such as iNOS and
COX-2, which are increased both in human CRC and in
AOM-induced rat colon carcinogenesis(9). Increased
expression of iNOS and, to a lesser extent, of COX-2 occurred
early in AOM-induced colon carcinogenesis in rats(32). iNOS
expression is frequently observed in dysplastic, but not in
hyperplastic, ACF, indicating that iNOS plays an important
role in the early stages of tumour formation(32). On the
other hand, tumorigenic mechanisms of COX-2 include the
inhibition of apoptosis via increased Bcl-2 and the activation
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Fig. 5. Effect of cocoa polyphenolic extract (CPE) on NF-kB translocation and phosphorylated levels of extracellular signal-regulated kinases (ERK), c-Jun NH2-
terminal kinases (JNK) and p38 MAPK (p38) induced by TNF-a in Caco-2 cells. C ( ): control, untreated cells; TNF-a ( ): cells treated with 40 ng/ml TNF-a for
1 h; CPE ( ): cells treated with 10mg/ml CPE for 20 h; CPE þ TNF-a ( ): cells pretreated with 10mg/ml CPE for 20 h and then treated with 40 ng/ml TNF-a for
1 h. NF-kB levels were determined by Western blot in the nuclear or cytosolic cellular compartment. Values are means, with standard deviations represented
by vertical bars. (A) Representative bands of three different experiments. (B) Percentage values of nuclear ( ) and cytosolic NF-kB ( ) levels relative to the
control condition. Phosphorylated and total levels of ERK, JNK and p38 were determined by Western blot analysis using phospho- and total specific antibodies.
(C) Bands are representative of two to three different experiments. (D) Percentage values of the p-ERK:ERK, p-JNK:JNK and p-p38:p38 ratios relative to the
control condition. a,b,c,d Mean values with unlike letters were significantly different (P,0·05).
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of proliferation via MAPK or phosphoinositide 3-kinase–AKT
signalling pathways(33). More importantly, the effect of a
cocoa-rich diet preventing iNOS and COX-2 expression induced
by AOM is consistent with our previous report showing that
a cocoa-rich diet prevents the increase in proliferation evoked
by AOM and induces apoptosis(16). Therefore, as previously
described by other naturally occurring phytochemicals, such
as b-carotene, epigallocatechin gallate or silibinin(11), the
reduction in the pro-inflammatory mediators iNOS and COX-2
in association with the inhibition of ACF formation suggests
that a cocoa-rich diet is effective for the primary prevention
of inflammation-related carcinogenesis in the rat colon.
One of the most important anti-inflammatory mecha-
nisms of some phenolic compounds is the activation of
NF-kB(11,19). NF-kB is considered to be an important transcrip-
tion factor in the tumorigenic process because its constitutive
activation exerts strong proliferative and anti-apoptotic prop-
erties in cancer cells(3). In resting cells, NF-kB is sequestered
in the cytoplasm by interaction with inhibitors, such as IkB
and related proteins. In response to stimulation, IkB is phos-
phorylated, ubiquitinated and degraded, allowing NF-kB
dimers (p65 and p50) to translocate to the nucleus for promot-
ing the transcription of target genes including the pro-inflam-
matory enzymes iNOS and COX-2(34). Interestingly, the results
of the present study show that the increased levels of NF-kB
(p65) in the nucleus of epithelial colonic cells of AOM-
treated rats were significantly decreased by the cocoa diet,
suggesting that the inhibitory effects of the cocoa diet on
COX-2 and iNOS expression may be mediated by the inhi-
bition of NF-kB activation. These findings are consistent
with other studies showing that natural chemo-preventive
agents suppress both iNOS and COX-2 levels by regulating
NF-kB signalling(35,36). Overall, the suppression of NF-kB
signalling by a cocoa-rich diet contributes to the reduction
in AOM-induced formation and the development of colonic
ACF in rats.
In response to oxidative and pro-inflammatory stimuli,
NF-kB is activated, at least in part, by a series of upstream
kinases, including those belonging to the MAPK family pro-
teins, such as ERK, JNK and p38 MAPK. Recent in vitro studies
have demonstrated that cocoa phenolic compounds can
regulate several signal transduction pathways(22,37) and tran-
scription factors(38,39), and thus modulate the expression of
specific genes to exert their function(40). In the present
study, we confirmed that a CPE obtained from the same
cocoa used in the in vivo study significantly reduced the
increase in inflammatory markers such as IL-8 secretion,
COX-2 and iNOS expression induced by the pro-inflammatory
agent TNF-a in Caco-2 cells. In addition, we showed that CPE
selectively reduced both the phosphorylation of JNK and the
nuclear translocation of NK-kB induced by TNF-a, indicating
that this pathway could be an important mechanism contri-
buting to the reduction of intestinal inflammation associated
with cocoa feeding. Similar results have been found in pre-
vious reports indicating that several natural compounds
could contribute to the inhibition of inflammation by blocking
MAPK signalling and NF-kB(11). More importantly, it has
recently been demonstrated that JNK inhibition could prevent
inflammatory bowel disease(41). Altogether, the mechanisms
by which cocoa polyphenols reduced the expression of
inflammatory markers seem to be partly due to their ability
to inhibit JNK phosphorylation and NF-kB activation.
Considerable evidence has demonstrated that oxidative
stress is involved in the link between chronic inflammation
and cancer(42). In fact, the activation of NF-kB by nearly all
stimuli can be blocked by antioxidants, such as cysteine,
N-acetylcysteine, thiols, green tea polyphenols and vitamin
E(43,44). Other than flavonoids, CPE also contains a high
quantity of theobromine. In this regard, we have previously
tested the potential participation of dimethylxanthine in the
protection against oxidative stress in a cell culture model(21)
and the results showed that the contribution of theobromine
to the antioxidative ability of CPE is negligible. Accordingly,
we suggest that the preventive effect of CPE in the inflamma-
tory process is mostly provided by the flavonoid fraction.
However, the potential synergistic effects between the bio-
active cocoa components, flavanols and methylxanthines,
need much further investigation and cannot be ruled out.
Interestingly, for many individuals, cocoa products consti-
tute a larger proportion of the diet than foodstuffs containing
bioactive compounds with similar properties such as green
tea, wine or soyabeans(45–47). Indeed, when compared with
other flavonoid-containing foodstuffs, cocoa products exhibit
a high concentration of procyanidins that are poorly absorbed
in the intestine and consequently their beneficial effects would
be restricted to the gastrointestinal tract where they may
have an important antioxidant and anti-inflammatory local
function(48). Furthermore, using the body surface area normal-
isation method(49), the amount of cocoa employed in the
present animal study is equivalent to a daily dose of 78 g
cocoa, containing 1560 mg polyphenols, for a 60 kg human.
Although this phenolic intake could be considered realistic,
the amount of cocoa required is certainly above a rec-
ommended individual ingestion. Accordingly, a human
intervention trial has been conducted using 20 g/d of
polyphenol-rich dark chocolate containing 1000 mg polyphe-
nols(50). This dose of 20 g/d of dark chocolate represents
5–10 % of dietary energy, an amount that most people could
readily incorporate into their diet.
In summary, the present study shows that cocoa poly-
phenols posses a potent anti-inflammatory effect in vivo
and in vitro on the colonic tissue. At the molecular level,
the inhibition of JNK/MAPK and NF-kB activation and the
down-regulation of iNOS and COX-2 expression seem to
play an important role in the prevention of intestinal inflam-
mation. Therefore, together with their inherent antioxidant
effects, cocoa polyphenols are able to reduce colon inflam-
mation as a complementary mechanism of chemo-prevention
in the early stages of chemical carcinogen-induced colonic
ACF formation and development. Taken together, the present
data provide evidence that cocoa polyphenols would offer
a natural approach to improve individual health status inclu-
ding the prevention of intestinal inflammation with minimal
toxicity.
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